EP
Eversept Partners’s TG Therapeutics TGTX Stock Holding History
Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q3 | – | Sell |
-69,760
| Closed | -$2.71M | – | 110 |
|
2021
Q2 | $2.71M | Sell |
69,760
-692,829
| -91% | -$26.9M | 0.18% | 50 |
|
2021
Q1 | $36.8M | Sell |
762,589
-101,262
| -12% | -$4.88M | 2.76% | 10 |
|
2020
Q4 | $44.9M | Sell |
863,851
-159,479
| -16% | -$8.3M | 5.27% | 4 |
|
2020
Q3 | $27.4M | Sell |
1,023,330
-1,477,942
| -59% | -$39.5M | 6.08% | 3 |
|
2020
Q2 | $48.7M | Buy |
2,501,272
+40,135
| +2% | +$782K | 6.68% | 2 |
|
2020
Q1 | $24.2M | Buy |
2,461,137
+1,684,814
| +217% | +$16.6M | 6.02% | 4 |
|
2019
Q4 | $8.62M | Buy |
776,323
+2,822
| +0.4% | +$31.3K | 1.52% | 17 |
|
2019
Q3 | $4.34M | Sell |
773,501
-110,000
| -12% | -$618K | 1.35% | 18 |
|
2019
Q2 | $7.64M | Buy |
883,501
+134,907
| +18% | +$1.17M | 2.14% | 12 |
|
2019
Q1 | $6.02M | Buy |
748,594
+683,594
| +1,052% | +$5.5M | 1.76% | 16 |
|
2018
Q4 | $267K | Hold |
65,000
| – | – | 0.14% | 49 |
|
2018
Q3 | $364K | Sell |
65,000
-15,000
| -19% | -$84K | 0.16% | 52 |
|
2018
Q2 | $1.05M | Sell |
80,000
-70,000
| -47% | -$921K | 0.48% | 40 |
|
2018
Q1 | $2.13M | Buy |
+150,000
| New | +$2.13M | 0.99% | 22 |
|